Breast Cancer Patients at Increased Risk of Developing Type II Endometrial Cancer: Relative and Absolute Risk Estimation and Implications for Counseling-Reference-Cited by-同舟云学术

Breast Cancer Patients at Increased Risk of Developing Type II Endometrial Cancer: Relative and Absolute Risk Estimation and Implications for Counseling

Published:2021-01-29 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Portela Sara,Cunningham Aimee,Laios Alexandros,Hutson Richard,Theophilou Georgios

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference28 articles.

1. Endometrial cancer;Sorosky JI;Obstet Gynecol,2008

2. Type I and II endometrial cancers: have they different risk factors?;Setiawan VW;J Clin Oncol,2013

3. Factors associated with Type I and Type II endometrial cancer;Felix AS;Cancer Causes Control,2010

4. Endometrial cancer incidence in breast cancer patients correlating with age and duration of tamoxifen use: a population based study;Chen JY;J Cancer,2014

5. Elevated risks of subsequent endometrial cancer development among breast cancer survivors with different hormone receptor status: a SEER analysis;Liu J;Breast Cancer Res Treat,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Checkpoint Inhibitors Targeting the PD-1/PD-L1 Pathway in Advanced, Recurrent Endometrial Cancer: A Scoping Review with SWOT Analysis;Cancers;2023-09-19

2. Endometrial Cancer Risk Among Germline BRCA1/2 Pathogenic Variant Carriers: Review of Our Current Understanding and Next Steps;JCO Precision Oncology;2023-09

3. Tamoxifen use and risk of endometrial cancer in breast cancer patients: A systematic review and dose–response meta‐analysis;Cancer Reports;2023-03-14

4. Breast Cancer Patients Are at Increased Risk of Developing Uterine Serous Cancer: Implications for Counseling – A SEER Analysis;Oncology Research and Treatment;2022